Publication | Closed Access
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids
75
Citations
0
References
1977
Year
Metabolic SyndromeLipid SynthesisBiochemistryLipid NutritionMedicinePhysiologyLiver Fat ContentLiver WeightMetabolismLipidsMetabolomicsLipid ChemistryPharmacologyRmi 14514-2-Furancarboxylic AcidHealth Sciences
5-(Tetradecyloxy)-2-furancarboxylic acid (91, RMI 14514) was found to lower blood lipids and to inhibit fatty acid synthesis with minimal effects on liver weight and liver fat content. This fatty acid-like compound represents a new class of hypolipidemic agent; it is effective in rats and monkeys. The compound resulted from discovery of hypolipidemic activity in certain beta-keto esters, postulation and confirmation of the corresponding benzoic acids as active metabolites, and systematic exploration of the structure--activity relationships.